EUVIMEDEUVIMED entdecken
Crossref

A Sustainable Retinal Drug Co‐Delivery for Boosting Therapeutic Efficacy in wAMD: Unveiling Multifaceted Evidence and Synergistic Mechanisms

Congyan Liu, Wenting Su, Xi Jiang, Yanli Lv, Fei Kong, Qin Chen, Qun Zhang, Huangqin Zhang, Yuping Liu, Xiaoqi Li, Xinrong Xu, Yan Chen und 1 weitere

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202303659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Congyan Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, 100 Hongshan Road, Nanjing, 21002…. Hauptthemen laut MEDLINE: Pyrazines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Province Key Research and Development Program for Social Development Project, Natural Science Foundation of Jiangsu Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sustainable retinal codelivery poses significant challenges technically, although it is imperative for synergistic treatment of wet age‐related macular degeneration (wAMD). Here, a microemulsion‐doped hydrogel (Bor/PT‐M@TRG) is engineered as an intravitreal depot composing of temperature‐responsive hydrogel (TRG) and borneol‐decorated paeoniflorin (PF) & tetramethylpyrazine (TMP)‐coloaded microemulsions (Bor/PT‐M). Bor/PT‐M@TRG, functioning as the “ammunition depot”, resides in the vitreous and continuously releases Bor/PT‐M as the therapeutic “bullet”, enabling deep penetration into the retina for 21 days. A single intravitreal injection of Bor/PT‐M@TRG yields substantial reductions in choroidal neovascularization (CNV, a hallmark feature of wAMD) progression and mitigates oxidative stress‐induced damage in vivo. Combinational PF&TMP regulates the “reactive oxygen species/nuclear factor erythroid‐2‐related factor 2/heme oxygenase‐1” pathway and blocks the “hypoxia inducible factor‐1α/vascular endothelial growth factor” signaling in retina, synergistically cutting off the loop of CNV formation. Utilizing fluorescence resonance energy transfer and liquid chromatography‐mass spectrometry techniques, they present compelling multifaceted evidence of sustainable retinal codelivery spanning formulations, ARPE‐19 cells, in vivo eye balls, and ex vivo section/retina‐choroid complex cell levels. Such codelivery approach is elucidated as the key driving force behind the exceptional therapeutic outcomes of Bor/PT‐M@TRG. These findings highlight the significance of sustainable retinal drug codelivery and rational combination for effective treatment of wAMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazinesAnimalsRetinaMacular DegenerationDrug Delivery SystemsHumansChoroidal NeovascularizationMiceHydrogelsOxidative StressCamphanesMice, Inbred C57BLReactive Oxygen Species

Stichwörter der Autor:innen

choroidal neovascularizationmicroemulsionretinal drug deliveryretinal pigment epitheliumwet age‐related macular degeneration

Substanzen

PyrazinestetramethylpyrazineHydrogelsCamphanesReactive Oxygen Species

Autor:innen und Institutionen

  • Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, 100 Hongshan Road, Nanjing, 210028, P. R. China.
  • Jiangsu Provincial Academy of Traditional Chinese Medicine, 100 Hongshan Road, Nanjing, 210028, P. R. China.
  • Department of Ophthalmology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, P. R. China.
  • Department of Ophthalmology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, 155 Hanzhong Road, Nanjing, 210029, P. R. China.

ORCID-Profile: Ding Qu

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Province Key Research and Development Program for Social Development Project
  • Natural Science Foundation of Jiangsu Province of China
  • Key Science and Technology Project of Jiangsu Provincial Administration of Traditional Chinese Medicine
  • General Project of Jiangsu Provincial Health Commission
  • Open Project of Chinese Materia Medica First-Class Discipline of Nanjing University of Chinese Medicine
  • 333 project
  • Project 333 of Jiangsu Province

Zitieren

APA

Liu, C., Su, W., Jiang, X., Lv, Y., Kong, F., Chen, Q., Zhang, Q., Zhang, H., Liu, Y., Li, X., Xu, X., Chen, Y., & Qu, D. (2024). A Sustainable Retinal Drug Co‐Delivery for Boosting Therapeutic Efficacy in wAMD: Unveiling Multifaceted Evidence and Synergistic Mechanisms. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303659

Vancouver

Liu C, Su W, Jiang X, Lv Y, Kong F, Chen Q, et al. A Sustainable Retinal Drug Co‐Delivery for Boosting Therapeutic Efficacy in wAMD: Unveiling Multifaceted Evidence and Synergistic Mechanisms. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303659

BibTeX
@article{Liu2024,
  author = {Liu, Congyan and Su, Wenting and Jiang, Xi and Lv, Yanli and Kong, Fei and Chen, Qin and Zhang, Qun and Zhang, Huangqin and Liu, Yuping and Li, Xiaoqi and Xu, Xinrong and Chen, Yan and Qu, Ding},
  title = {A Sustainable Retinal Drug Co‐Delivery for Boosting Therapeutic Efficacy in wAMD: Unveiling Multifaceted Evidence and Synergistic Mechanisms},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202303659}
}
Kostenlos starten →